Tumor necrosis factor α (TNF-α) inhibitors have long been used for the treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS), as well as other inflammatory conditions [1,2,3]. Here, TNF is linked to ankylosing spondylitis.